News | October 06, 2010

Arteriotomy Devices Reasonable, But More Research Needed

October 6, 2010 – A new statement from the American Heart Association says arteriotomy closure devices are reasonable to use, but their benefits should be weighed against the risk of complications.

Arteriotomy, the process of creating a hole in an access artery through which instruments are inserted, is the first step in procedures such as angiography or percutaneous coronary intervention (PCI). Closing up the artery is a concern due to possible bleeding complications.

Arteriotomy closure is typically done with manual compression, but more devices are entering the market to offer potential improvements over manual closure. The statement is published in Circulation: Journal of the American Heart Association.

The statement authors conclude that the devices are reasonable to use - and they offer recommendations for their use based on available evidence - but their benefits should be weighed against the risk of complications in patients. Patient-specific factors such as age, gender and disease severity should be considered before using an arteriotomy closure device.

The statement also includes recommendations for future trials and end points needed to inform clinical practice.

In the United States, 1.3 million PCI procedures were performed in 2006, the most recent year for which data is available.

For more information: www.heart.org

Related Content

Vascular Solutions, Teleflex
Feature | December 07, 2016
December 7, 2016 — Teleflex Inc. and Vascular Solutions Inc.
angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices| October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc.
Vivasure Medical, Closure Device, Series C financing
News | Vascular Closure Devices| September 12, 2016
September 12, 2016 — Vivasure Medical announced last week that the company has completed a Series C financing of €16.
nanoparticles, blood clotting, internal bleeding, American Chemical Society study, Erin B. Lavik

Nanoparticles (green) help form clots in an injured liver. The researchers added color to the scanning electron microscopy image after it was taken. Image courtesy of Erin Lavik, Ph.D.

News | Hemostasis Management| August 24, 2016
August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to...
Rex medical, Closer Vascular Sealing System, VSS, vascular closure, bioresorbable vascular closure device

A close up view of the Rex Medical Closer Vascular Sealing System components.

Technology | Vascular Closure Devices| August 03, 2016
August 3, 2016 — The U.S.
Vivasure Medical, PerQSeal, vascular closure device, CE Mark
News | Vascular Closure Devices| January 18, 2016
Vivasure Medical announced Conformité Européenne (CE) Mark approval of the world’s first fully bioabsorbable...
News | Hemostasis Management| January 06, 2016
The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which certain subsidiaries...
News | Vascular Closure Devices| December 16, 2015
Scientists at CBSET have presented preclinical evidence that the Manta Large Bore Vascular Closure Device (VCD) from...
platelet-like particles, PLPs, clotting, substitute, Carver, Lyon, NIBIB

Cartoon representation of a deformable platelet-like particle with fibrin nanobodies attached

Feature | Antiplatelet and Anticoagulation Therapies| July 13, 2015
Researchers have created tiny gel particles that can perform the same essential functions as platelets. The particles...
News | March 30, 2015
The Medicines Company announced that the European Commission has granted marketing authorization for two acute care...
Overlay Init